-
Product Insights
NewCollagen Alpha 1 – Drugs In Development, 2024
The Collagen Alpha 1 pipeline drugs market research report outlays comprehensive information on the Collagen Alpha 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Dermatology, Genetic Disorders, Respiratory, and Immunology which include indications of Epidermolysis Bullosa, Burns, Familial Adenomatous Polyposis, Cystic Fibrosis, and Graft Versus Host Disease (GVHD). It also reviews key players involved in Collagen...
-
Product Insights
Innovations in Collagens – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Collagens - Global Pipeline Summary" provides comprehensive information about the Collagens pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Collagens report provides key information and data related to: Extensive coverage of the Collagens under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifaximin in Collagenous Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin in Collagenous Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaximin in Collagenous Colitis Drug Details: Rifaximin (Xifaxan / Normix /...
-
Product Insights
Innovations in Antimicrobial Collagen Dressings – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Antimicrobial Collagen Dressings - Global Pipeline Summary" provides comprehensive information about the Antimicrobial Collagen Dressings pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Antimicrobial Collagen Dressings report provides key information and data related to: Extensive coverage of the Antimicrobial Collagen Dressings under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLN-617 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CLN-617 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CLN-617 in Metastatic Melanoma Drug Details: CLN-617 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLN-617 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CLN-617 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CLN-617 in Solid Tumor Drug Details: CLN-617 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLN-617 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CLN-617 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CLN-617 in Head And Neck Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ZKN-013 in Epidermolysis Bullosa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ZKN-013 in Epidermolysis Bullosa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ZKN-013 in Epidermolysis Bullosa Drug Details: ZKN-013 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiomolibdate Diammonium in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiomolibdate Diammonium in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tiomolibdate Diammonium in Triple-Negative Breast Cancer (TNBC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AD-214 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AD-214 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AD-214 in Chronic Kidney Disease (Chronic Renal...